Literature DB >> 16409259

Ivermectin: pharmacology and application in dermatology.

Assen L Dourmishev1, Lyubomir A Dourmishev, Robert A Schwartz.   

Abstract

Ivermectin is a synthetic derivative of the antiparasitic class of compounds known as avermectins. It is a macrolide endectocide with activity against both endoparasites with cutaneous tropism (Strongyloides stercoralis, Ancylostoma braziliense, Cochliomyia hominivorax, Dermatobia hominis, Filaria bancrofti, Wucheria malayi, Onchocerca volvulus, Loa-loa) and ectoparasites such as Sarcoptes scabies, Pediculus humanus, Demodex folliculorum, and Cheyletiella sp. Ivermectin is of great interest in the treatment of patients with different forms of scabies, head lice, demodecidosis, cutaneous larva migrans, cutaneous larva currens, myiasis, and filariasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16409259     DOI: 10.1111/j.1365-4632.2004.02253.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  29 in total

Review 1.  The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug.

Authors:  Mandy Juarez; Alejandro Schcolnik-Cabrera; Alfonso Dueñas-Gonzalez
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

2.  Skin and soft tissue infections and envenomations acquired at the beach.

Authors:  Joseph P Myers
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

Review 3.  The pharmacokinetics and interactions of ivermectin in humans--a mini-review.

Authors:  Aránzazu González Canga; Ana M Sahagún Prieto; M José Diez Liébana; Nélida Fernández Martínez; Matilde Sierra Vega; Juan J García Vieitez
Journal:  AAPS J       Date:  2008-01-25       Impact factor: 4.009

4.  Ivermectin worthy of further investigation.

Authors:  Andrew C Steer; Therese Kearns; Ross M Andrews; James S McCarthy; Jonathan R Carapetis; Bart J Currie
Journal:  Bull World Health Organ       Date:  2009-10       Impact factor: 9.408

5.  Oral ivermectin as an unexpected initiator of CreT2-mediated deletion in T cells.

Authors:  Evann Corbo-Rodgers; Elizabeth S Staub; Tao Zou; Abigail Smith; Taku Kambayashi; Jonathan S Maltzman
Journal:  Nat Immunol       Date:  2012-02-16       Impact factor: 25.606

6.  Household-wide ivermectin treatment for head lice in an impoverished community: randomized observer-blinded controlled trial.

Authors:  Daniel Pilger; Jorg Heukelbach; Adak Khakban; Fabiola Araujo Oliveira; Gernot Fengler; Hermann Feldmeier
Journal:  Bull World Health Organ       Date:  2009-12-21       Impact factor: 9.408

7.  Wound myiasis: the role of entodermoscopy.

Authors:  João Renato Vianna Gontijo; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

8.  Cutaneous larva migrans with optic disc edema: a case report.

Authors:  Luna Dhir; Tim O'Dempsey; Mark T Watts
Journal:  J Med Case Rep       Date:  2010-07-07

9.  Scabies outbreak among healthcare workers in a German acute care hospital.

Authors:  Rasmus Leistner; Dirk Buchwald; Marc Beyer; Sandra Philipp
Journal:  J Infect Prev       Date:  2017-02-01

10.  Community management of endemic scabies in remote aboriginal communities of northern Australia: low treatment uptake and high ongoing acquisition.

Authors:  Sophie La Vincente; Therese Kearns; Christine Connors; Scott Cameron; Jonathan Carapetis; Ross Andrews
Journal:  PLoS Negl Trop Dis       Date:  2009-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.